With the help of DNA testing company Natera and its personalized molecular residual disease (MRD) blood test Signatera, Roche ...

Natera said the Food and Drug Administration approved its Signatera CDx as a test for bladder cancer. The drug can be used as a companion diagnostic with adjuvant atezolizumab to treat muscle-invasive ...

Bladder cancer is one of the most common, and most overlooked, cancers in the United States, impacting hundreds of thousands of families each year. This is a public health issue that touches families, ...

The assay delivers a risk score that can help clinicians to tailor treatment intensity to a patient's risk of disease progression.

AstraZeneca said on Thursday that a late-stage trial of Imfinzi, combined with ​a targeted therapy prior to a ‌surgery, ...

My son is struggling with paruresis, and it has taken over his life. He cannot work, avoids family gatherings and feels like he can’t plan for relationships or ...

One nurse shares how AxonicsTM Therapy helped her regain bladder and bowel control.

Would I have preferred to be knocked out by general anesthesia so I wouldn’t feel a thing? Sure, but total body sedation for ...

Every single type of cancer, explained A cancer diagnosis can be both terrifying and confusing for those afflicted, as well ...

Last month, I briefly covered the topic of bladder cancer, looking at the causes and symptoms of this disease. This month, I ...

Qlucore, listed on Nasdaq First North, is launching a new Qlucore Insights test (Research Use Only) specifically developed for bladder cancer samples. The software-based test delivers multiple ...

Bladder cancer arises from the lining of the bladder, the organ that stores urine, and is one of the most common cancers in the United States. Most patients are diagnosed at an early stage called ...